Granules Life Sciences gets US FDA EIR for Hyderabad facility

Regulatory Product ApprovalBusiness Updates View source PDF Explain this filing

GRANULES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹565.20

prior close

₹574.65

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.8%+0.7% vs market

Pharmaceuticals peers, median of 155sector+0.1%+1.4% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Smallcap 250 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.4

15m

-0.3

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6+0.8+0.7+0.1+1.4

Next day

+1.2+1.2-0.0-0.1+1.3

+1.7+0.4+1.3-0.5+2.3

+2.4-0.3+2.7-1.2+3.6

+3.0-0.4+3.4-1.4+4.4

+3.2+0.9+2.3-0.6+3.8

+9.0+2.3+6.7+0.3+8.7

15d

+6.9+3.6+3.3+0.5+6.4

+5.2-1.0+6.2-2.7+7.9

+0.8-0.1+0.9-3.3+4.1

+3.5-6.1+9.6-8.6+12.1

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Granules India wholly owned subsidiary Granules Life Sciences (GLS) has received an Establishment Inspection Report (EIR) from the US FDA. The EIR follows an inspection of its Hyderabad facility conducted from July 28 to August 1, 2025. GLS manufactures PFI and Finished Dosages. The EIR confirms the facility meets FDA quality standards and regulatory requirements.

Likely market impact

Positive for shareholders - US FDA clearance for subsidiary plant removes a regulatory overhang and supports continued US market supplies.